This was the stock's fourth consecutive day of gains.

B iotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to develop one or or even a handful of world-changing drug ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Bio-Techne Corporation today announced it will showcase its new ProPaktm GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy development and ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children's Therapeutics, a division of the Seattle Children's Research Institute ...